Myectomy: Still the Gold Standard for HOCM

An expert panel comprised of many of the world’s top HCM experts recently published a retrospective analysis in The American Journal of Cardiology which looked at septal myectomy over the last 60 years of practice.

 Beginning with the introduction of the procedure at the National Institute of Health in the early 1960s, this paper surveys the history of the procedure until the present day.  The conclusion of the paper is that myectomy remains the best treatment for patients with obstructive hypertrophic cardiomyopathy.

Continue reading “Myectomy: Still the Gold Standard for HOCM”

Positive Myectomy Outcomes for Patients 65+

According to a recent retrospective study at Oregon Health & Sciences University, appropriately selected patients 65 or older who underwent septal myectomy for obstructive hypertrophic cardiomyopathy (HOCM) have surgical outcomes similar to younger patients. Therefore, older age should NOT be an automatic disqualifier for myectomy. All potential treatments for outflow tract obstruction should be considered, with age being only one of many factors influencing the decision.  

Alternative to Myectomy?

Could this minimally invasive procedure prove to be a viable alternative to septal myectomy or alcohol ablation for septal reduction?

Doctors at Minneapolis Heart Institute are planning a larger, multi-center trial to test the viability of this procedure as a larger scale treatment for HCM.

Surgery Riskier for HCM Patients

 

According to a recent article in the British Cardiac Society’s Heart, HCM patients have a higher complication rate associated with unrelated non-cardiac surgeries than non-HCM patient undergoing similar procedures.  Hence, HCM patients undergoing surgery should receive increased attention during and after surgery.